• Something wrong with this record ?

Genetic testing in children enrolled in epilepsy surgery program. A real-life study

B. Straka, B. Splitkova, M. Vlckova, P. Tesner, H. Rezacova, L. Krskova, M. Koblizek, M. Kyncl, A. Maulisova, K. Bukacova, A. Uhrova-Meszarosova, A. Musilova, M. Kudr, M. Ebel, A. Belohlavkova, A. Jahodova, P. Liby, M. Tichy, P. Jezdik, J....

. 2023 ; 47 (-) : 80-87. [pub] 20231005

Language English Country England, Great Britain

Document type Journal Article

OBJECTIVE: Although genetic causes of drug-resistant focal epilepsy and selected focal malformations of cortical development (MCD) have been described, a limited number of studies comprehensively analysed genetic diagnoses in patients undergoing pre-surgical evaluation, their outcomes and the effect of genetic diagnosis on surgical strategy. METHODS: We analysed a prospective cohort of children enrolled in epilepsy surgery program over January 2018-July 2022. The majority of patients underwent germline and/or somatic genetic testing. We searched for predictors of surgical outcome and positive result of germline genetic testing. RESULTS: Ninety-five patients were enrolled in epilepsy surgery program and 64 underwent resective epilepsy surgery. We ascertained germline genetic diagnosis in 13/74 patients having underwent germline gene testing (pathogenic or likely pathogenic variants in CHRNA4, NPRL3, DEPDC5, FGF12, GRIA2, SZT2, STXBP1) and identified three copy number variants. Thirty-five patients underwent somatic gene testing; we detected 10 pathogenic or likely pathogenic variants in genes SLC35A2, PTEN, MTOR, DEPDC5, NPRL3. Germline genetic diagnosis was significantly associated with the diagnosis of focal epilepsy with unknown seizure onset. SIGNIFICANCE: Germline and somatic gene testing can ascertain a definite genetic diagnosis in a significant subgroup of patients in epilepsy surgery programs. Diagnosis of focal genetic epilepsy may tip the scales against the decision to proceed with invasive EEG study or surgical resection; however, selected patients with genetic focal epilepsies associated with MCD may benefit from resective epilepsy surgery and therefore, a genetic diagnosis does not disqualify patients from presurgical evaluation and epilepsy surgery.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24000813
003      
CZ-PrNML
005      
20240716074227.0
007      
ta
008      
240109e20231005enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejpn.2023.09.009 $2 doi
035    __
$a (PubMed)37812946
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Straka, Barbora $u Department of Paediatric Neurology, Motol Epilepsy Center, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Full Member of the ERN EpiCARE, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: barbora.straka@fnmotol.cz $7 xx0319616
245    10
$a Genetic testing in children enrolled in epilepsy surgery program. A real-life study / $c B. Straka, B. Splitkova, M. Vlckova, P. Tesner, H. Rezacova, L. Krskova, M. Koblizek, M. Kyncl, A. Maulisova, K. Bukacova, A. Uhrova-Meszarosova, A. Musilova, M. Kudr, M. Ebel, A. Belohlavkova, A. Jahodova, P. Liby, M. Tichy, P. Jezdik, J. Zamecnik, E. Aronica, P. Krsek
520    9_
$a OBJECTIVE: Although genetic causes of drug-resistant focal epilepsy and selected focal malformations of cortical development (MCD) have been described, a limited number of studies comprehensively analysed genetic diagnoses in patients undergoing pre-surgical evaluation, their outcomes and the effect of genetic diagnosis on surgical strategy. METHODS: We analysed a prospective cohort of children enrolled in epilepsy surgery program over January 2018-July 2022. The majority of patients underwent germline and/or somatic genetic testing. We searched for predictors of surgical outcome and positive result of germline genetic testing. RESULTS: Ninety-five patients were enrolled in epilepsy surgery program and 64 underwent resective epilepsy surgery. We ascertained germline genetic diagnosis in 13/74 patients having underwent germline gene testing (pathogenic or likely pathogenic variants in CHRNA4, NPRL3, DEPDC5, FGF12, GRIA2, SZT2, STXBP1) and identified three copy number variants. Thirty-five patients underwent somatic gene testing; we detected 10 pathogenic or likely pathogenic variants in genes SLC35A2, PTEN, MTOR, DEPDC5, NPRL3. Germline genetic diagnosis was significantly associated with the diagnosis of focal epilepsy with unknown seizure onset. SIGNIFICANCE: Germline and somatic gene testing can ascertain a definite genetic diagnosis in a significant subgroup of patients in epilepsy surgery programs. Diagnosis of focal genetic epilepsy may tip the scales against the decision to proceed with invasive EEG study or surgical resection; however, selected patients with genetic focal epilepsies associated with MCD may benefit from resective epilepsy surgery and therefore, a genetic diagnosis does not disqualify patients from presurgical evaluation and epilepsy surgery.
650    _2
$a dítě $7 D002648
650    _2
$a lidé $7 D006801
650    _2
$a prospektivní studie $7 D011446
650    12
$a epilepsie $x genetika $x chirurgie $x komplikace $7 D004827
650    12
$a epilepsie parciální $x komplikace $7 D004828
650    _2
$a genetické testování $7 D005820
650    12
$a refrakterní epilepsie $x diagnóza $x genetika $x chirurgie $7 D000069279
650    12
$a malformace mozkové kůry $x genetika $7 D054220
650    _2
$a proteiny aktivující GTPasu $x genetika $7 D020690
650    _2
$a fibroblastové růstové faktory $x genetika $7 D005346
650    _2
$a proteiny nervové tkáně $x genetika $7 D009419
655    _2
$a časopisecké články $7 D016428
700    1_
$a Splitkova, Barbora $u Department of Paediatric Neurology, Motol Epilepsy Center, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Full Member of the ERN EpiCARE, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: barbora.splitkova@fnmotol.cz
700    1_
$a Vlckova, Marketa $u Department of Biology and Medical Genetics, Motol Epilepsy Center, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Motol University Hospital, Full Member of the ERN EpiCARE, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: marketa.vlckova@fnmotol.cz
700    1_
$a Tesner, Pavel $u Department of Biology and Medical Genetics, Motol Epilepsy Center, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Motol University Hospital, Full Member of the ERN EpiCARE, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: pavel.tesner@fnmotol.cz
700    1_
$a Rezacova, Hana $u Department of Biology and Medical Genetics, Motol Epilepsy Center, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Motol University Hospital, Full Member of the ERN EpiCARE, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: hana.rezacova@fnmotol.cz
700    1_
$a Krskova, Lenka $u Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Full Member of the ERN EpiCARE, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: lenka.krskova@fnmotol.cz
700    1_
$a Koblizek, Miroslav $u Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Full Member of the ERN EpiCARE, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: miroslav.koblizek@fnmotol.cz
700    1_
$a Kyncl, Martin $u Department of Radiology, Motol Epilepsy Center, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Full Member of the ERN EpiCARE, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: martin.kyncl@fnmotol.cz
700    1_
$a Maulisova, Alice $u Department of Clinical Psychology, Motol University Hospital, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: alice.maulisova@fnmotol.cz
700    1_
$a Bukacova, Katerina $u Department of Clinical Psychology, Motol University Hospital, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: katerina.bukacova@fnmotol.cz
700    1_
$a Uhrova-Meszarosova, Anna $u Department of Paediatric Neurology, Motol Epilepsy Center, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Full Member of the ERN EpiCARE, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: Anna.Meszarosova@seznam.cz
700    1_
$a Musilova, Alena $u Department of Paediatric Neurology, Motol Epilepsy Center, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Full Member of the ERN EpiCARE, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: alena.musilova@lfmotol.cuni.cz
700    1_
$a Kudr, Martin $u Department of Paediatric Neurology, Motol Epilepsy Center, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Full Member of the ERN EpiCARE, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: martin.kudr@fnmotol.cz
700    1_
$a Ebel, Matyas $u Department of Paediatric Neurology, Motol Epilepsy Center, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Full Member of the ERN EpiCARE, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: matyas.ebel@fnmotol.cz
700    1_
$a Belohlavkova, Anezka $u Department of Paediatric Neurology, Motol Epilepsy Center, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Full Member of the ERN EpiCARE, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: anezka.belohlavkova@fnmotol.cz
700    1_
$a Jahodova, Alena $u Department of Paediatric Neurology, Motol Epilepsy Center, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Full Member of the ERN EpiCARE, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: alena.jahodova@fnmotol.cz
700    1_
$a Liby, Petr $u Department of Neurosurgery, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Full Member of the ERN EpiCARE, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: petr.liby@fnmotol.cz
700    1_
$a Tichy, Michal $u Department of Neurosurgery, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Full Member of the ERN EpiCARE, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: michal.tichy@fnmotol.cz
700    1_
$a Jezdik, Petr $u Faculty of Electrical Engineering, Department of Circuit Theory, Czech Technical University in Prague, Technicka 2, Praha 6, 166 27, Czech Republic. Electronic address: jezdip1@fel.cvut.cz
700    1_
$a Zamecnik, Josef $u Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Full Member of the ERN EpiCARE, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: josef.zamecnik@fnmotol.cz
700    1_
$a Aronica, Eleonora $u Amsterdam UMC Location University of Amsterdam, Department of Neuropathology, Amsterdam Neuroscience, the Netherlands; Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, the Netherlands. Electronic address: e.aronica@amsterdamumc.nl
700    1_
$a Krsek, Pavel $u Department of Paediatric Neurology, Motol Epilepsy Center, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Full Member of the ERN EpiCARE, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: pavel.krsek@post.cz
773    0_
$w MED00149836 $t European journal of paediatric neurology $x 1532-2130 $g Roč. 47 (20231005), s. 80-87
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37812946 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240716074224 $b ABA008
999    __
$a ok $b bmc $g 2049429 $s 1210507
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 47 $c - $d 80-87 $e 20231005 $i 1532-2130 $m European journal of paediatric neurology $n Eur J Paediatr Neurol $x MED00149836
LZP    __
$a Pubmed-20240109

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...